The news came as Roche recorded a 10% increase in first-quarter revenues to CHF 16.4 billion ($17.2 billion), on strong US demand for rapid COVID-19 antigen tests, as well as the performances of ...
Roche : lance un nouveau centre de recherche à Boston 07/03 CF Roche érige un centre d'innovation sur le campus de Harvard 07/03 AW Roche lance un centre de recherche au Harvard's Enterprise ...
In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...
Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics , the Wall Street Journal reported on Wednesday, citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback